Market-Moving News for March 4th
Benzinga Newsdesk 1 year ago
MoversTrading Ideas
CAPR: 20% | Capricor Therapeutics shares are trading higher after the FDA accepted and granted priority review for the company's Biologics License Application for Deramiocel to treat Duchenne Muscular
